Litium AB (publ) (STO:LITI)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	219	125	143	176	231	427
Market Cap Growth	12.44%	-12.33%	-18.87%	-23.76%	-45.99%	241.51%
Enterprise Value	215	116	132	149	215	408
Last Close Price	13.20	7.54	8.60	10.60	17.50	32.40
PE Ratio	-	176.49	-	-	-	-
Forward PE	88.00	143.62	-	-	-	-
PS Ratio	2.59	1.52	1.82	2.40	3.40	7.51
PB Ratio	2.63	1.47	1.69	2.00	3.49	7.88
P/TBV Ratio	170.25	22.55	18.22	9.58	40.00	63.10
P/FCF Ratio	12.80	7.98	14.77	-	-	-
P/OCF Ratio	12.64	7.93	14.67	-	-	-
EV/Sales Ratio	2.54	1.41	1.69	2.03	3.16	7.18
EV/EBITDA Ratio	-	142.14	-	-	-	-
EV/EBIT Ratio	-	188.32	-	-	-	-
EV/FCF Ratio	12.55	7.40	13.72	-	-	-
Debt / Equity Ratio	-	-	-	-	0.01	0.04
Asset Turnover	0.83	0.81	0.75	0.76	0.84	0.90
Quick Ratio	0.98	1.15	1.26	1.74	1.10	1.23
Current Ratio	1.05	1.33	1.45	1.92	1.25	1.27
Return on Equity (ROE)	-1.39%	0.83%	-3.97%	-16.16%	-21.38%	-43.40%
Return on Assets (ROA)	-0.79%	0.38%	-2.01%	-8.08%	-9.92%	-17.63%
Return on Capital (ROIC)	-0.96%	0.45%	-2.43%	-10.06%	-13.04%	-24.60%
Return on Capital Employed (ROCE)	-	0.70%	-	-	-	-
Earnings Yield	-0.53%	0.57%	-2.40%	-7.08%	-5.58%	-4.45%
FCF Yield	7.81%	12.53%	6.77%	-0.44%	-2.02%	-1.93%
Buyback Yield / Dilution	-6.60%	-8.51%	-6.20%	-12.40%	-18.87%	-16.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.